Scientech Research’s enGene Therapeutics ENGN Stock Holding History
Bought
Maintained
Sold
Other funds holding ENGN
BCM
SL
ACA
Scientech Research's ENGN Position: Q2 2026 in Review
Scientech Research opened a new position in enGene Therapeutics (ENGN) in Q2 2026: 40,710 shares worth $70.4K. The stake represents 0.06% of the portfolio and ranks #185 among its holdings.
60 funds tracked by Wall St. Rank hold ENGN as of Q2 2026.
- Scientech Research held 40,710 shares of enGene Therapeutics worth $70.4K as of Q2 2026.
- enGene Therapeutics was a new Scientech Research position in Q2 2026.
- enGene Therapeutics made up 0.06% of Scientech Research's portfolio in Q2 2026, its #185 holding.
- 60 funds tracked by Wall St. Rank held enGene Therapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.